Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
. Given the medicinal chemistry–driven nature of this project, we are specifically seeking a candidate with documented experience in lead optimization, including structure–activity relationship (SAR
-
microbes in the human gut – and the development of cardiometabolic diseases (CMD) such as obesity, type 2 diabetes, and cardiovascular disease. The goal is to generate knowledge that can lead to new
-
institution dedicated to the comprehensive study of cultural and social conditions. Our research explores the relationship between humanity and its environments, including nature, technology, and theology
-
background checks may be conducted on qualified candidates for the position. DTU Bioengineering is an important contributor to the areas of biotechnology, food technology, and human and animal health, through
-
, internet of things (IoT), chip design, cybersecurity, human-computer interaction, social networks, fairness, and data ethics. Our research is rooted in basic research and centres on mathematical models
-
affects both human and animal health. Our group plays a key role as an EU, WHO, and FAO reference laboratory for antimicrobial resistance. We provide scientific advisory services, as well as applied and
-
. The Somyajit laboratory has a strong interest in uncovering the regulatory foundations of the cell cycle, DNA replication, chromatin regulation, and genome surveillance in human pathophysiology. The lab
-
scientist with the following competencies and experience: Necessary experience and skills: You have a PhD in Human Nutrition, Medicine or a related field. You are highly experienced in managing randomized
-
Three-Year Postdoc Opportunity in Ecosystem Structure, Functions and Services in Offshore Marine ...
environmental challenges linked to the balance between human activities and protection levels of the North Sea and Wadden Sea, our demonstration site located in Denmark. Candidate Profile: We are looking for a
-
combination with tumor characterization, revealing tumor networks in prostate cancer progression. Key findings will be validated on human samples, and their functions will be assessed in vivo through CRISPR